Skip to main content
OpenTrials
Completed

NCT Number: NCT06678412

Turkish Version of the Cognitive Functioning Self-Assessment Scale

Self-report scales used in the assessment of cognitive functions can serve as an initial screening tool for the general population, aside from specific neuropsychiatric tests, which are more costly and time-consuming. This study is designed to examine the validity and reliability of the Turkish version of the Cognitive Functioning Self-Assessment Scale (CFSS). Permission for the study has been obtained from the developer of the scale, Dr. Maria Antonietta Annunziata. The Turkish translation of the scale will be made, and approval will be obtained from the original author for the final version. Subsequently, the Turkish version of the CFSS, the Hospital Anxiety and Depression Scale, and the Cognitive Failures Questionnaire will be administered to participants. Surveys will be completed either online via Google Forms or in written form. To assess the reliability of the scale, the Turkish version of the CFSS will be re-administered to the same participants 7-14 days later.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kutahya Health Sciences University

Kütahya, 43100, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals over 18 years old

Exclusion criteria

  • Taking antidepressants
  • Having a neurological or psychiatric disease

Treatment and study plan

Primary outcomes

  1. Cognitive Functioning Self-Assessment Scale (Turkish Vesion)

    Time frame: Baseline and 7-14 days after

    The "Cognitive Functioning Self-Assessment Scale" developed by Annunziata et al. in 2016, consists of 18 questions aimed at assessing cognitive function areas such as attention, memory, problem-solving, temporal-spatial orientation, and dual-task performance. Scoring is done on a 5-point Likert scale, ranging from 1 to 5. Higher scores on the scale indicate an increase in subjective cognitive complaints.

  2. Hospital Anxiety and Depression Scale (HADS)

    Time frame: Baseline

    The HADS was developed by Zigmond and Snaith in 1983. The HADS consists of a total of 14 items, including 7 items for anxiety and 7 items for depression. The items are scored between 0-3 points on a 4-point Likert-type scale according to how the individual felt in the previous week. The scores that can be obtained from anxiety and depression subscales vary between 0-21. The Turkish validity and reliability study of the scale was conducted by Aydemir et al. in 1997. High scores obtained from the scale indicate increased mood disorder.

  3. Cognitive Failures Questionnaire (CFQ)

    Time frame: Baseline

    The BDI is a self-report scale developed by Broadbent et al. in 1982 to assess cognitive failures that occur in daily life. Errors in perception, memory and motor functions are assessed with 25 questions. Each question is scored from 0 (never) to 4 (very often). The total score that can be obtained from the scale ranges from 0-100. Higher scores indicate an increased level of cognitive failure and worse cognitive status. The Turkish validity and reliability study of the scale was conducted by Ekici et al. in 2016.

Sponsors and collaborators

Lead sponsor

Kutahya Health Sciences University

Other

Registry information

Official study title

The Validity and Reliability of the Turkish Version of the Cognitive Functioning Self-Assessment Scale

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 7, 2024
Registry last updated
Mar 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.